2
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Guanethidine in the Treatment of Hypertension

, , &
Pages 260-264 | Published online: 18 Apr 2016

REFERENCES

  • Page, I. H. and Dustan, H. P.: A new, potent antihypertensive drug. J.A.M.A. 170: 1265, 1959.
  • Frohlich, E. D. and Freis, E. D.: Clinical trial of guanethidine, a new type of antihypertensive agent. M. Ann. District of Columbia 28: 419, 1959.
  • Brest, A. N., Duarte, C., Glantz, G. and Moyer, J. H.: Preliminary observations on the antihypertensive properties of guanethidine. Current Therap. Res. 2: 17, 1960.
  • Richardson, D. W., Wyso, E. M., Magee, J. H. and Cavell, G. C.: Circulatory effects of guanethidine. Clinical, renal and cardiac responses to treatment with a novel antihypertensive drug. Circulation 22: 184, 1960.
  • Maxwell, R. A., Plummer, A. J., Schneider, F., Povalski, H. and Daniel, A. I.: Pharmacology of 2-(octahydro-l-azocinyl)-ethyl guanidine sulfate (SU-5864). J. Pharmacol. & Exper. Therap. 128: 22, 1960.
  • Moyer, J. H. and Hershberger, R. L.: The effect of pentolinium on renal hemodynamics and water and electrolyte excretion: A comparison with hexa-methonium. Am. J. M. Sc. 231: 294, 1956.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.